|
|
|
Volumn 19, Issue SUPPL. H, 1998, Pages
|
|
Baseline characteristics of patients participating in the Bezafibrate Infarction Prevention (BIP) study
a
|
|
Author keywords
Bezafibrate; Coronary heart disease; Lipid modification
|
|
Indexed keywords
ANTILIPEMIC AGENT;
BEZAFIBRATE;
CHOLESTEROL;
FIBRINOGEN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
TRIACYLGLYCEROL;
ADULT;
AGED;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED STUDY;
CORONARY RISK;
FEMALE;
FIBRINOGEN BLOOD LEVEL;
HEART INFARCTION;
HUMAN;
ISCHEMIC HEART DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TRIACYLGLYCEROL BLOOD LEVEL;
ADULT;
AGED;
ANTILIPEMIC AGENTS;
BEZAFIBRATE;
CHOLESTEROL;
FEMALE;
FIBRINOGEN;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
TREATMENT OUTCOME;
TRIGLYCERIDES;
|
|
EID: 0031856716
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (50)
|
|
References (24)
|
